← 產業報告目錄
Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type, indication, end-user and route of administration, Region And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-01頁數 180報告編號 INSIGHTACE-c1f355ed9a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 13.1 Bn as of 2023, the global Medical Nutrition Market is expected to climb to USD 20.2 Bn by 2031, reflecting a compound annual growth rate of 5.7% over the 2024–2031 period.
At its core, Medical Nutrition pertains to The escalating occurrence of malnutrition among adults and the surge in obesity rates, coupled with the rising prevalence of chronic diseases like cancer and diabetes, are primary drivers propelli. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Medical nutrition Market Snapshot
Chapter 4. Global Medical nutrition Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Nutrition Type Estimates & Trend Analysis
5.1. by Nutrition Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Nutrition Type:
5.2.1. Proteins
5.2.2. Carbohydrates
5.2.3. Multivitamins & Antioxidants
5.2.4. Amino Acids
5.2.5. Fibers
5.2.6. Minerals
5.2.7. Others
Chapter 6. Market Segmentation 2: by Indication Estimates & Trend Analysis
6.1. by Indication & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Indication:
6.2.1. Diabetes
6.2.2. Cancer
6.2.3. Gastrointestinal Diseases
6.2.4. Metabolic Syndromes
6.2.5. Others
Chapter 7. Market Segmentation 3: by Patient Type Estimates & Trend Analysis
7.1. by Patient Type & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Patient Type:
7.2.1. Infant Nutrition
7.2.2. Adult Nutrition
7.2.3. Geriatric Nutrition
Chapter 8. Market Segmentation 4: by Route of Administration Estimates & Trend Analysis
8.1. by Route of Administration & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
8.2.1. Oral
8.2.2. Enteral
8.2.3. Parenteral
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
9.2.1. Hospitals
9.2.2. Home Care Settings
9.2.3. Long Term Car
9.2.4. Ambulatory Surgical Centers
Chapter 10. Medical nutrition Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.1.2. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.1.3. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.1.4. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration,2019-2031
10.1.5. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.1.6. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.2.2. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.2.3. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.2.4. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
10.2.5. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.2.6. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.3.2. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.3.3. Asia-Pacific Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.3.4. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration,2019-2031
10.3.5. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.3.6. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.4.2. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.4.3. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.4.4. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration ,2019-2031
10.4.5. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.4.6. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.5.2. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.5.3. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.5.4. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
10.5.5. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.5.6. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott
11.2.2. Danone S.A.
11.2.3. Baxter
11.2.4. Nestlé
11.2.5. GSK plc.
11.2.6. Sun Pharmaceutical Industries Ltd.
11.2.7. Sanofi
11.2.8. DSM
11.2.9. BASF SE
11.2.10. Fresenius SE & Co. KGaA
11.2.11. Leprino Foods Company
11.2.12. Fresenius Kabi Ltd
11.2.13. Sparer Onco Nutrition
11.2.14. Kate Farms
11.2.15. Guardion Health Sciences, Inc.
11.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們